Authors


Brett King, MD, PhD

Latest:

Recent Advances in the Treatment of Alopecia Areata

In this MEDcast episode, Raj Chovatiya, MD, PhD, and George Han, MD, PhD, interview Brett King, MD, PhD, to discuss the latest advances in the treatment of alopecia areata.


Mark Sulkowski, MD

Latest:

The Future and Resources in HCV Care

Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.


Kim Zuber, PA-C

Latest:

Sick Day Rules in Nephrology, with Kim Zuber, PA-C, and Jane Davis, DNP

In their latest column, Kim Zuber, PA-C, and Jane Davis, DNP, break down the concept of "sick day rules" and what this means for providers caring for those with kidney disease.


Ravi Shah, MD

Latest:

Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial

Findings from a novel study supports the JAK inhibitor tofacitinib as a potential first-line therapy for ASUC.


Lindsay S. Ackerman, MD, FAAD

Latest:

Emerging Treatments for Atopic Dermatitis

Looking to the future of atopic dermatitis treatment, the panel discusses ongoing research and promising emerging therapies.


Dareen Siri, MD, FAAAAI, FACAAI

Latest:

Final Thoughts on Treatment of Asthma

Raffi Tachdjian, MD, MPH, FAAAAI, FACAAI; Dareen D. Siri, MD, FAAAAI, FACAAI; Nicole Chase, MD, FAAP, FACAAI, FAAAAI; and Andrew White, MD, give final thoughts on asthma management, considering the current treatment landscape.


Kris Kowdley, MD, FACP, FACG, AGAF, FAASLD

Latest:

Unmet Needs in the Treatment of PBC

Experts in hepatology review the unmet needs in primary biliary cholangitis, commenting on liver transplant, ethnic disparities, management of pruritis, as well as other symptoms.


Henry Nasrallah, MD, University of Cincinnati College of Medicine

Latest:

Schizophrenia: Practice, Patients, and Treatment

A panel of experts in schizophrenic psychiatric care share their thoughts on the practice, patients, and treatment based on their years of experience.


Benjamin Kaffenberger, MD

Latest:

Patient Subgroups and Educational Opportunities in Rare Dermatological Disorders

Dermatological experts discuss challenges that are associated with the use of standard and emerging treatments in special patient population.


Mithu Maheswaranathan, MD

Latest:

Inflammatory Back Pain in Malignancy Mimics Spondyloarthritis

Malignancy-related IBP has distinct features: shorter diagnosis time, higher ESR/CRP/LDH, lower hemoglobin, and often involves metastasis or paraneoplastic causes.


Yi Qin, MD

Latest:

A Deep Dive Into the 2022 ACG GERD Guideline Update

A review of changes to clinical, dietary and screening strategies for patients with GERD.


Andrew Skinner, MD

Latest:

Key Takeaways on FMTs in the Treatment of CDI

Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.


Nirmish Ramesh Shah, MD, Duke University

Latest:

Sickle Cell Disease: Unmet Needs and Future Directions in Care

Concluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.


Aleksandra Rachitskaya, MD, FASRS

Latest:

Achieving Superior Treatment Durability and Outcomes In Neovascular AMD and DME

Expert retina specialists discuss the latest therapies that could reduce the treatment burden and provide superior clinical outcomes in retinal diseases.


Patricia Ares-Romero, MD, FASAM

Latest:

Optimizing the Management of TRD

An expert panel shares insight on the future treatment landscape for treatment-resistant depression.


TJ Chao, MPAS, PA-C

Latest:

Selecting Appropriate Therapy in the Evolving Treatment Landscape of Plaque Psoriasis

Expert dermatology physician assistants share how to select the appropriate therapy for your patient with plaque psoriasis in an expanding treatment landscape.


Diana Do, MD

Latest:

Perspectives on the Future of Retinal Disease Management

Experts conclude this series highlighting what is on the horizon of retinal disease care.


Alexa Hetzel, MS, PA-C

Latest:

Clinical Pearls and Educational Needs in Plaque Psoriasis

Experts in dermatology share practice pearls to advanced practice providers and community dermatologists for the management of plaque psoriasis.


Connor Iapoce

Latest:

Gildeuretinol for Stargardt Secures FDA Rare Pediatric, Fast Track Status

FDA grants Rare Pediatric Disease, Fast Track designations to gildeuretinol, aiming to accelerate treatment for Stargardt disease.


Dominic Sisti, PhD

Latest:

Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medical Assistance in Dying

In part 2 of this 2-part discussion, hosts discuss ethical considerations and the growing evidence base around euthanasia and medical assistance in dying.



Heather Woolery-Lloyd, MD

Latest:

Resources for Patients With Vitiligo

Ted Lain, MD, reviews available support groups, vitiligo education, and other resources for patients with the disease.


Mark Lebwohl, MD

Latest:

When to Switch a Drug Class in Psoriasis Treatment

Experts conclude the series discussing how to approach switching psoriasis treatments.



George Han, MD, PhD

Latest:

Future Outlook for Atopic Dermatitis Treatments

Medical experts share their final thoughts on the future of atopic dermatitis treatment with oral systemic agents.


Regino P. Gonzalez-Peralta, MD

Latest:

Clinical Pearls for the Management of ALGS

Experts in pediatric hepatology share advice for the optimal management of Alagille syndrome.



Stephen Scheinthal, DO, DFACN, DFAPA, CS

Latest:

Screening for Alzheimer’s Disease: Facilitating an Early Diagnosis for Prompt Intervention

In this episode of MEDcast, expert geriatric psychiatrists explore the urgent need for effective diagnostic methods that can detect Alzheimer’s disease at an early stage. We will discuss blood-based biomarkers and other advancements that can help screen Alzheimer’s disease non-invasively and early in the disease course.



Jessica Allegretti, MD, MPH

Latest:

Emerging Treatments Over the Horizon for IBD

Jessica Allegretti, MD, MPH, and Edward Loftus Jr., MD, review emerging agents in the later phases for the management of IBD.

© 2024 MJH Life Sciences

All rights reserved.